PDB Short entry for 5TO8 HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-OCT-16 5TO8 TITLE SELECTIVITY SWITCH BETWEEN FAK AND PYK2: MACROCYCLIZATION OF FAK TITLE 2 INHIBITORS IMPROVES PYK2 POTENCY COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN-TYROSINE KINASE 2-BETA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 414-692; COMPND 5 SYNONYM: CALCIUM-DEPENDENT TYROSINE KINASE,CADTK,CALCIUM-REGULATED COMPND 6 NON-RECEPTOR PROLINE-RICH TYROSINE KINASE,CELL ADHESION KINASE BETA, COMPND 7 CAKB,FOCAL ADHESION KINASE 2,FADK 2,PROLINE-RICH TYROSINE KINASE 2, COMPND 8 RELATED ADHESION FOCAL TYROSINE KINASE,RAFTK; COMPND 9 EC: 2.7.10.2; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PTK2B, FAK2, PYK2, RAFTK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Z.E.NEWBY REVDAT 2 06-MAR-24 5TO8 1 REMARK REVDAT 1 21-DEC-16 5TO8 0 JRNL AUTH J.FARAND,N.MAI,J.CHANDRASEKHAR,Z.E.NEWBY,J.VAN VELDHUIZEN, JRNL AUTH 2 J.LOYER-DREW,C.VENKATARAMANI,J.GUERRERO,A.KWOK,N.LI, JRNL AUTH 3 Y.ZHEREBINA,S.WILBERT,J.ZABLOCKI,G.PHILLIPS,W.J.WATKINS, JRNL AUTH 4 R.MOUREY,G.T.NOTTE JRNL TITL SELECTIVITY SWITCH BETWEEN FAK AND PYK2: MACROCYCLIZATION OF JRNL TITL 2 FAK INHIBITORS IMPROVES PYK2 POTENCY. JRNL REF BIOORG. MED. CHEM. LETT. V. 26 5926 2016 JRNL REFN ESSN 1464-3405 JRNL PMID 27876318 JRNL DOI 10.1016/J.BMCL.2016.10.092 REMARK 2 REMARK 2 RESOLUTION. 1.98 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.2_1309 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.98 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.12 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 20419 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.850 REMARK 3 FREE R VALUE TEST SET COUNT : 2012 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.1269 - 4.7819 0.98 1340 135 0.2077 0.2089 REMARK 3 2 4.7819 - 3.7963 1.00 1339 152 0.1776 0.2006 REMARK 3 3 3.7963 - 3.3166 1.00 1325 138 0.2012 0.2598 REMARK 3 4 3.3166 - 3.0134 1.00 1329 148 0.2127 0.2302 REMARK 3 5 3.0134 - 2.7975 1.00 1323 140 0.2246 0.2671 REMARK 3 6 2.7975 - 2.6326 1.00 1329 150 0.2097 0.2431 REMARK 3 7 2.6326 - 2.5008 1.00 1311 144 0.2081 0.2525 REMARK 3 8 2.5008 - 2.3919 1.00 1361 136 0.2007 0.2378 REMARK 3 9 2.3919 - 2.2998 1.00 1300 154 0.2055 0.2604 REMARK 3 10 2.2998 - 2.2205 1.00 1313 150 0.2139 0.2473 REMARK 3 11 2.2205 - 2.1510 1.00 1332 152 0.2037 0.2486 REMARK 3 12 2.1510 - 2.0896 1.00 1321 135 0.2028 0.2548 REMARK 3 13 2.0896 - 2.0346 1.00 1335 150 0.2105 0.2542 REMARK 3 14 2.0346 - 1.9849 0.90 1149 128 0.2089 0.2511 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.300 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2013 REMARK 3 ANGLE : 1.033 2741 REMARK 3 CHIRALITY : 0.070 308 REMARK 3 PLANARITY : 0.005 339 REMARK 3 DIHEDRAL : 15.454 729 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TO8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1000224546. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20507 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.985 REMARK 200 RESOLUTION RANGE LOW (A) : 43.117 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 22.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 19% PEG1000, 100 MM LISULFATE, 50 MM REMARK 280 DISODIUM HYDROGEN PHOSPHATE, 50 MM CITRIC ACID, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 46.78250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 411 REMARK 465 SER A 412 REMARK 465 MET A 413 REMARK 465 GLY A 414 REMARK 465 GLY A 415 REMARK 465 PRO A 416 REMARK 465 GLN A 417 REMARK 465 TYR A 418 REMARK 465 GLY A 419 REMARK 465 LEU A 465 REMARK 465 ASP A 466 REMARK 465 GLU A 495 REMARK 465 GLU A 496 REMARK 465 ILE A 543 REMARK 465 ASN A 544 REMARK 465 TYR A 573 REMARK 465 ILE A 574 REMARK 465 GLU A 575 REMARK 465 ASP A 576 REMARK 465 GLU A 577 REMARK 465 ASP A 578 REMARK 465 TYR A 579 REMARK 465 TYR A 580 REMARK 465 LYS A 581 REMARK 465 ALA A 582 REMARK 465 SER A 583 REMARK 465 VAL A 584 REMARK 465 THR A 585 REMARK 465 ARG A 586 REMARK 465 LEU A 587 REMARK 465 PRO A 588 REMARK 465 GLU A 692 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 426 CG1 CG2 REMARK 470 HIS A 447 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 448 CG CD CE NZ REMARK 470 GLU A 450 CG CD OE1 OE2 REMARK 470 ILE A 452 CG1 CG2 CD1 REMARK 470 LYS A 461 CG CD CE NZ REMARK 470 LYS A 468 CG CD CE NZ REMARK 470 GLU A 469 CG CD OE1 OE2 REMARK 470 LYS A 470 CG CD CE NZ REMARK 470 MET A 472 CG SD CE REMARK 470 GLU A 474 CG CD OE1 OE2 REMARK 470 LYS A 479 CG CD CE NZ REMARK 470 GLU A 494 CG CD OE1 OE2 REMARK 470 ARG A 516 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 553 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 561 CG CD OE1 OE2 REMARK 470 ARG A 572 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 600 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 601 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 602 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 632 CG CD CE NZ REMARK 470 LYS A 640 CG CD CE NZ REMARK 470 LEU A 649 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 600 15.00 59.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7FM A 701 DBREF 5TO8 A 414 692 UNP Q14289 FAK2_HUMAN 414 692 SEQADV 5TO8 GLY A 411 UNP Q14289 EXPRESSION TAG SEQADV 5TO8 SER A 412 UNP Q14289 EXPRESSION TAG SEQADV 5TO8 MET A 413 UNP Q14289 EXPRESSION TAG SEQRES 1 A 282 GLY SER MET GLY GLY PRO GLN TYR GLY ILE ALA ARG GLU SEQRES 2 A 282 ASP VAL VAL LEU ASN ARG ILE LEU GLY GLU GLY PHE PHE SEQRES 3 A 282 GLY GLU VAL TYR GLU GLY VAL TYR THR ASN HIS LYS GLY SEQRES 4 A 282 GLU LYS ILE ASN VAL ALA VAL LYS THR CYS LYS LYS ASP SEQRES 5 A 282 CYS THR LEU ASP ASN LYS GLU LYS PHE MET SER GLU ALA SEQRES 6 A 282 VAL ILE MET LYS ASN LEU ASP HIS PRO HIS ILE VAL LYS SEQRES 7 A 282 LEU ILE GLY ILE ILE GLU GLU GLU PRO THR TRP ILE ILE SEQRES 8 A 282 MET GLU LEU TYR PRO TYR GLY GLU LEU GLY HIS TYR LEU SEQRES 9 A 282 GLU ARG ASN LYS ASN SER LEU LYS VAL LEU THR LEU VAL SEQRES 10 A 282 LEU TYR SER LEU GLN ILE CYS LYS ALA MET ALA TYR LEU SEQRES 11 A 282 GLU SER ILE ASN CYS VAL HIS ARG ASP ILE ALA VAL ARG SEQRES 12 A 282 ASN ILE LEU VAL ALA SER PRO GLU CYS VAL LYS LEU GLY SEQRES 13 A 282 ASP PHE GLY LEU SER ARG TYR ILE GLU ASP GLU ASP TYR SEQRES 14 A 282 TYR LYS ALA SER VAL THR ARG LEU PRO ILE LYS TRP MET SEQRES 15 A 282 SER PRO GLU SER ILE ASN PHE ARG ARG PHE THR THR ALA SEQRES 16 A 282 SER ASP VAL TRP MET PHE ALA VAL CYS MET TRP GLU ILE SEQRES 17 A 282 LEU SER PHE GLY LYS GLN PRO PHE PHE TRP LEU GLU ASN SEQRES 18 A 282 LYS ASP VAL ILE GLY VAL LEU GLU LYS GLY ASP ARG LEU SEQRES 19 A 282 PRO LYS PRO ASP LEU CYS PRO PRO VAL LEU TYR THR LEU SEQRES 20 A 282 MET THR ARG CYS TRP ASP TYR ASP PRO SER ASP ARG PRO SEQRES 21 A 282 ARG PHE THR GLU LEU VAL CYS SER LEU SER ASP VAL TYR SEQRES 22 A 282 GLN MET GLU LYS ASP ILE ALA MET GLU HET 7FM A 701 39 HETNAM 7FM 25-(METHYLSULFONYL)-8-(TRIFLUOROMETHYL)-5,17,18,21,22, HETNAM 2 7FM 23,24,25-OCTAHYDRO-12H-7,11-(AZENO)-16,13-(METHENO) HETNAM 3 7FM PYRIDO[3,2-I]PYRROLO[1,2-Q][1,3,7,11, HETNAM 4 7FM 17]PENTAAZACYCLOHENICOSIN-20(6H)-ONE FORMUL 2 7FM C25 H26 F3 N7 O3 S FORMUL 3 HOH *83(H2 O) HELIX 1 AA1 ALA A 421 GLU A 423 5 3 HELIX 2 AA2 LYS A 468 LEU A 481 1 14 HELIX 3 AA3 GLU A 509 ASN A 517 1 9 HELIX 4 AA4 LYS A 522 SER A 542 1 21 HELIX 5 AA5 ALA A 551 ARG A 553 5 3 HELIX 6 AA6 SER A 593 ARG A 600 1 8 HELIX 7 AA7 THR A 603 SER A 620 1 18 HELIX 8 AA8 GLU A 630 LYS A 632 5 3 HELIX 9 AA9 ASP A 633 LYS A 640 1 8 HELIX 10 AB1 PRO A 651 TRP A 662 1 12 HELIX 11 AB2 ASP A 665 ARG A 669 5 5 HELIX 12 AB3 ARG A 671 MET A 691 1 21 SHEET 1 AA1 5 VAL A 425 GLU A 433 0 SHEET 2 AA1 5 GLU A 438 THR A 445 -1 O GLU A 441 N ARG A 429 SHEET 3 AA1 5 LYS A 451 LYS A 457 -1 O ILE A 452 N TYR A 444 SHEET 4 AA1 5 TRP A 499 GLU A 503 -1 O MET A 502 N ALA A 455 SHEET 5 AA1 5 LEU A 489 ILE A 493 -1 N ILE A 490 O ILE A 501 SHEET 1 AA2 2 VAL A 546 HIS A 547 0 SHEET 2 AA2 2 LEU A 570 SER A 571 -1 O SER A 571 N VAL A 546 SHEET 1 AA3 2 ILE A 555 SER A 559 0 SHEET 2 AA3 2 CYS A 562 LEU A 565 -1 O LYS A 564 N LEU A 556 SITE 1 AC1 14 LEU A 431 GLY A 432 GLU A 433 VAL A 487 SITE 2 AC1 14 MET A 502 GLU A 503 LEU A 504 TYR A 505 SITE 3 AC1 14 GLY A 508 GLU A 509 ARG A 553 LEU A 556 SITE 4 AC1 14 ASP A 567 HOH A 844 CRYST1 37.625 93.565 43.214 90.00 93.85 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026578 0.000000 0.001786 0.00000 SCALE2 0.000000 0.010688 0.000000 0.00000 SCALE3 0.000000 0.000000 0.023193 0.00000